Last updated: 29 May 2022 at 5:21am EST

Leonard S Jacob Net Worth




The estimated Net Worth of Leonard S Jacob is at least 3.7 百万$ dollars as of 18 February 2021. Leonard Jacob owns over 15,321 units of Antares Pharma Inc stock worth over 1,500,149$ and over the last 12 years Leonard sold ATRS stock worth over 2,195,969$.

Leonard Jacob ATRS stock SEC Form 4 insiders trading

Leonard has made over 14 trades of the Antares Pharma Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Leonard exercised 15,321 units of ATRS stock worth 34,319$ on 18 February 2021.

The largest trade Leonard's ever made was selling 244,814 units of Antares Pharma Inc stock on 9 December 2019 worth over 1,133,489$. On average, Leonard trades about 32,731 units every 121 days since 2012. As of 18 February 2021 Leonard still owns at least 268,363 units of Antares Pharma Inc stock.

You can see the complete history of Leonard Jacob stock trades at the bottom of the page.



What's Leonard Jacob's mailing address?

Leonard's mailing address filed with the SEC is C/O ANTARES PHARMA, INC., 100 PRINCETON SOUTH, SUITE 300, EWING, NJ, 08628.

Insiders trading at Antares Pharma Inc

Over the last 12 years, insiders at Antares Pharma Inc have traded over 29,755,747$ worth of Antares Pharma Inc stock and bought 910,400 units worth 1,278,090$ . The most active insiders traders include James E Deerfield Mgmt L.P....James E Deerfield Mgmt L.P....Jacques Gonella. On average, Antares Pharma Inc executives and independent directors trade stock every 28 days with the average trade being worth of 751,296$. The most recent stock trade was executed by Anton Gueth on 8 July 2021, trading 100,000 units of ATRS stock currently worth 429,000$.



What does Antares Pharma Inc do?

Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), Covis Pharma (Covis), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma's FDA-approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. The Company also markets NOCDURNA® (desmopressin acetate) in the U.S., which was licensed from Ferring Pharmaceuticals.



What does Antares Pharma Inc's logo look like?

Antares Pharma Inc logo

Complete history of Leonard Jacob stock trades at Antares Pharma Inc

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
18 Feb 2021 Leonard S Jacob
ディレクター
オプション行使 15,321 2.24$ 34,319$
18 Feb 2021
268,363
9 Dec 2019 Leonard S Jacob
ディレクター
販売 244,814 4.63$ 1,133,489$
9 Dec 2019
212,749
31 Oct 2019 Leonard S Jacob
ディレクター
オプション行使 20,000 1.10$ 22,000$
31 Oct 2019
297,563
8 Apr 2019 Leonard S Jacob
ディレクター
オプション行使 92,078 0.53$ 48,801$
8 Apr 2019
331,970
29 Mar 2018 Leonard S Jacob
ディレクター
オプション行使 32,407 0.85$ 27,546$
29 Mar 2018
239,892
9 Oct 2017 Leonard S Jacob
ディレクター
販売 230,000 4.05$ 931,500$
9 Oct 2017
207,485
3 Apr 2017 Leonard S Jacob
ディレクター
オプション行使 41,762 1.65$ 68,907$
3 Apr 2017
240,647
1 Dec 2016 Leonard S Jacob
ディレクター
オプション行使 20,000 1.23$ 24,600$
1 Dec 2016
238,885
18 Mar 2016 Leonard S Jacob
ディレクター
購入する 50,000 0.72$ 36,000$
18 Mar 2016
218,885
20 Mar 2015 Leonard S Jacob
ディレクター
販売 23,500 2.68$ 62,980$
20 Mar 2015
168,885
11 Aug 2014 Leonard S Jacob
ディレクター
購入する 10,000 1.98$ 19,800$
11 Aug 2014
192,385
15 Jan 2014 Leonard S Jacob
ディレクター
オプション行使 11,400 0.50$ 5,700$
15 Jan 2014
138,229
17 May 2013 Leonard S Jacob
ディレクター
販売 17,000 4.00$ 68,000$
17 May 2013
126,829
16 Nov 2012 Leonard S Jacob
ディレクター
購入する 10,000 3.44$ 34,400$
16 Nov 2012
82,000


Antares Pharma Inc executives and stock owners

Antares Pharma Inc executives and other stock owners filed with the SEC include: